A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle

Vaccine

Volumn 29, Issue 39, 2011, Pages 6771-6780

  Lin, Feng ^a   Shen, Xuefei ^a   McCoy, Jay R ^a   Mendoza, Janess M ^a   Yan, Jian ^a   Kemmerrer, Steve V ^a   Khan, Amir S ^a   Weiner, David B ^b   Broderick, Kate E ^a   Sardesai, Niranjan Y ^a  

^a Inovio Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DNA delivery; DNA vaccine; Electroporation; Intradermal; Intramuscular

Indexed keywords

DNA VACCINE; VIRUS NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DUAL DEPTH DEVICE; ELECTROPORATION; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SKIN; STANDARD;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPORATION; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GUINEA PIGS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; RANDOM ALLOCATION; TRANSFECTION; VACCINES, DNA;

EID: 79957673598     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.057     Document Type: Article

References (46)

1. Tang D.C., DeVit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356(6365):152-154.
2. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259(5102):1745-1749.
3. Wang B., Ugen K.E., Srikantan V., Agadjanyan M.G., Dang K., Refaeli Y., et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993, 90(9):4156-4160.
4. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996, 184(4):1555-1560.
5. Fu T.M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 1997, 3(6):362-371.
6. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 1997, 158(10):4591-4601.
7. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev 2008, 9(10):776-788.
8. Abdulhaqq S.A., Weiner D.B. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 2008, 42(1-3):219-232.
9. Braun S. Muscular gene transfer using nonviral vectors. Curr Gene Ther 2008, 8(5):391-405.
10. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu Rev Immunol 1997, 15:617-648.
11. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999, 6(4):508-514.
12. Mir L.M., Bureau M.F., Rangara R., Schwartz B., Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci 1998, 321(11):893-899.
13. Babiuk S., Baca-Estrada M.E., Foldvari M., Middleton D.M., Rabussay D., Widera G., et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004, 110(1):1-10.
14. Liu J., Kjeken R., Mathiesen I., Barouch D.H. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol 2008, 82(11):5643-5649.
15. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000, 164(9):4635-4640.
16. Gronevik E., Tollefsen S., Sikkeland L.I., Haug T., Tjelle T.E., Mathiesen I. DNA transfection of mononuclear cells in muscle tissue. J Gene Med 2003, 5(10):909-917.
17. Shedlock D.J., Weiner D.B. DNA vaccination: antigen presentation and the induction of immunity. J Leukoc Biol 2000, 68(6):793-806.
18. Ahlen G., Soderholm J., Tjelle T., Kjeken R., Frelin L., Hoglund U., et al. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol 2007, 179(7):4741-4753.
19. Draghia-Akli R., Khan A.S., Brown P.A., Pope M.A., Wu L., Hirao L., et al. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models. Vaccine 2008, 26(40):5230-5237.
20. Muthumani K., Lankaraman K.M., Laddy D.J., Sundaram S.G., Chung C.W., Sako E., et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008, 26(40):5128-5134.
21. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 2007, 81(10):5257-5269.
22. Laddy D.J., Yan J., Khan A.S., Andersen H., Cohn A., Greenhouse J., et al. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 2009, 83(9):4624-4630.
23. Otten G., Schaefer M., Doe B., Liu H., Srivastava I., zur Megede J., et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 2004, 22(19):2489-2493.
24. Babiuk S., Baca-Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002, 20(27-28):3399-3408.
25. Hirao L.A., Draghia-Akli R., Prigge J.T., Yang M., Satishchandran A., Wu L., et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal Monkeypox challenge. J Infect Dis 2011, 203(January (1)):95-102.
26. Patel V., Valentin A., Kulkarni V., Rosati M., Bergamaschi C., Jalah R., et al. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 2010, 28(30):4827-4836.
27. Rosati M., Bergamaschi C., Valentin A., Kulkarni V., Jalah R., Alicea C., et al. DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad USA 2009, 106(37):15831-15836.
28. Wallace M., Evans B., Woods S., Mogg R., Zhang L., Finnefrock A.C., et al. Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults. Mol Ther 2009, 17(5):922-928.
29. Zhang L., Rabussay D. Progress toward the development of electroporation for muslce-targeted DNA vaccines. Coimbra, Portugal. Bioelectrochemistry 2005.
30. Daud A.I., DeConti R.C., Andrews S., Urbas P., Riker A.I., Sondak V.K., et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008, 26(36):5896-5903.
31. Gurunathan S., Wu C.Y., Freidag B.L., Seder R.A. DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol 2000, 12(August (4)):442-447.
32. Kaur R., Sachdeva G., Vrati S. Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein. J Infect Dis 2002, 185(1):1-12.
33. Li B.W., Rush A., Zhang S.R., Curtis K.C., Weil G.J. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filaria J 2004, 3(1):1.
34. Gronevik E., Mathiesen I., Lomo T. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J Gene Med 2005, 7(9):1246-1254.
35. Hirao L.A., Wu L., Khan A.S., Satishchandran A., Draghia-Akli R., Weiner D.B. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 2008, 26(3):440-448.
36. Babiuk S., Baca-Estrada M., Babiuk L.A., Ewen C., Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Rel 2000, 66(2-3):199-214.
37. Toebak M.J., Gibbs S., Bruynzeel D.P., Scheper R.J., Rustemeyer T. Dendritic cells: biology of the skin. Contact Dermat 2009, 60(1):2-20.
38. Roos A.K., Eriksson F., Timmons J.A., Gerhardt J., Nyman U., Gudmundsdotter L., et al. Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 2009, 4(9):e7226.
39. Zhang L., Widera G., Rabussay D. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant. Bioelectrochemistry (Amsterdam, Netherlands) 2004, 63(1-2):369-373.
40. Babiuk S., Baca-Estrada M.E., Foldvari M., Baizer L., Stout R., Storms M., et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 2003, 8(6):992-998.
41. Martinon F., Kaldma K., Sikut R., Culina S., Romain G., Tuomela M., et al. Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates. Hum Gene Ther 2009, 20(11):1291-1307.
42. Low L., Mander A., McCann K., Dearnaley D., Tjelle T., Mathiesen I., et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009, 20(11):1269-1278.
43. Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Therapy 2010 (October).
44. Chong S.Y., Egan M.A., Kutzler M.A., Megati S., Masood A., Roopchard V., et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007, 25(26):4967-4982.
45. Sun Y., Santra S., Buzby A.P., Mascola J.R., Nabel G.J., Letvin N.L. Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. Virology 2010, 406(1):48-55.
46. Hirao L.A., Wu L., Satishchandran A., Khan A.S., Draghia-Akli R., Finnefrock A.C., et al. Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. Mol Ther 2010, 18(8):1568-1576.